BACK · As filed with the SEC
IMAC Holdings cash flow statement, by fiscal year
The statement as IMAC Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD
| USD | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | Year ended Dec 31, 2018 Year ended Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||
| Profit or Loss | — | — | — | (10,542,247) | (5,542,438) | (6,951,589) | (3,784,873) |
| Net Income | — | (9,418,585) | (18,312,806) | — | — | — | — |
| Net loss | (9,045,827) | — | — | — | — | — | — |
| Net loss from discontinuing operations | (2,748,049) | — | — | — | — | — | — |
| Profit or Loss | (6,297,778) | — | — | — | — | — | — |
| Adjustments to reconcile net loss to net cash from operating activities: | |||||||
| Depreciation Expense | — | — | — | 1,649,187 | 1,722,465 | 1,552,919 | 651,066 |
| Non-Operating Income (Expense) | — | — | — | — | — | 639,159 | — |
| Stock-Based Compensation Expense | — | — | — | 570,513 | — | — | — |
| Loss on disposition of assets | — | — | — | 149,464 | — | — | — |
| Depreciation Expense | 139,182 | 403,593 | 1,626,614 | — | — | — | — |
| Interest Expense | 640,000 | — | — | — | — | — | — |
| Stock-Based Compensation Expense | 35,415 | 83,031 | 444,503 | — | 392,050 | 392,217 | 14,998 |
| Deferred rent | — | — | — | — | — | — | 133,238 |
| Equity in (earnings) loss of non-consolidated affiliate | — | — | — | — | — | — | (105,550) |
| Loss on disposition of assets | — | — | — | — | 63,779 | — | — |
| Loss on disposition of assets | — | 1,475,289 | 98,116 | — | — | — | — |
| Asset Impairment Charges | — | 3,519,322 | 8,333,687 | — | — | — | — |
| Gain on lease modification | — | — | — | (57,086) | — | — | — |
| Interest Expense | — | — | — | 312,857 | — | — | — |
| Provision for Doubtful Accounts (CF) | — | 431,671 | — | — | — | — | — |
| Gain on extinguishment of debt | — | (94,346) | — | — | (1,550,843) | — | — |
| Interest Expense | — | — | — | — | 237,143 | — | — |
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable, net | (28,030) | 1,449,569 | (1,671,906) | 304,350 | (234,518) | (412,805) | (170,235) |
| Due from related parties | — | — | — | — | — | — | (95,501) |
| Other assets | — | — | 180,178 | (158,834) | 162,891 | (271,654) | (70,038) |
| Other assets | — | 265,553 | — | — | — | — | — |
| Prepaid expenses and other current assets | 33,360 | — | — | — | — | — | — |
| Net Cash from Operating Activities | — | 196,121 | — | — | — | — | — |
| Net Cash from Operating Activities | — | 205,389 | 56,620 | 36,357 | 111,081 | (111,400) | (410,335) |
| Decrease in right of use/lease liability | — | — | — | (162,797) | — | — | — |
| Right of use/lease liability | — | — | (149,631) | — | — | — | — |
| Liability to issue common stock | — | (329,855) | — | — | — | — | — |
| Right of use/lease liability | — | (346,770) | — | — | — | — | — |
| Accounts payable and accrued expenses | 5,063,810 | (388,467) | (820,592) | 281,428 | (1,460,376) | 1,359,099 | 1,204,417 |
| Patient deposits | — | — | (79,251) | 25,846 | 105,380 | (264,689) | 323,474 |
| Lease incentive obligation | — | — | — | — | — | — | 516,026 |
| Patient deposits | — | (241,666) | — | — | — | — | — |
| Net cash used in operating activities from continuing operations | (414,041) | — | — | — | — | — | — |
| Net Cash from Operating Activities | (2,748,049) | — | — | — | — | — | — |
| Net cash used in operating activities | (3,162,090) | (2,790,151) | (10,294,468) | (7,590,962) | (5,993,386) | (4,068,743) | (1,808,310) |
| Cash flows from investing activities: | |||||||
| Purchase of property and equipment | — | — | (331,382) | (694,376) | (125,987) | (1,200,216) | (1,579,842) |
| Brand development | — | — | — | (69,070) | — | — | — |
| Purchase of license fee | — | — | — | — | (243,750) | — | — |
| Acquisitions | — | — | — | (1,718,500) | (200,000) | — | (23,931) |
| Note receivable | (375,000) | (3,000,000) | — | — | — | — | — |
| Proceeds from sale of practices | — | 224,700 | — | — | — | — | — |
| Proceeds from Sale of PP&E | — | 1,000,000 | 71,400 | 24,450 | — | 147,096 | — |
| Net cash used in investing activities | (375,000) | (1,775,300) | (259,982) | (2,457,496) | (569,737) | (1,053,120) | (1,603,773) |
| Cash flows from financing activities: | |||||||
| Net Cash from Financing Activities | — | — | — | — | — | 3,839,482 | — |
| Net Cash from Financing Activities | — | — | — | — | — | 357,345 | — |
| Stock Repurchases (Issuances) | — | 16,650 | 4,472,219 | 19,005,323 | 5,181,855 | 1,311,697 | — |
| Proceeds from Stock Issuance | 2,221,492 | 4,045,000 | — | — | — | — | — |
| Payments on notes payable | — | (10,350) | (254,488) | (4,436,375) | (1,505,055) | (123,348) | (193,625) |
| Payments of debt issuance costs | — | — | — | — | (157,500) | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | 20,000 | 175,000 |
| Payments on line of credit | — | — | — | — | (79,961) | (300,000) | (140,000) |
| Proceeds from Notes Payable | 1,600,000 | — | — | — | 5,391,520 | 212,800 | 3,998,195 |
| Payments on finance lease obligation | (1,724) | (27,549) | (19,050) | (25,462) | (17,473) | (16,740) | (25,642) |
| Deferred IPO costs | — | — | — | — | — | — | (335,318) |
| Net cash from financing activities | 3,819,768 | 4,023,751 | 4,198,681 | 14,543,486 | 8,813,386 | 5,301,236 | 3,478,610 |
| Net increase (decrease) in cash | 282,678 | (541,700) | (6,355,769) | 4,495,028 | 2,250,263 | 179,373 | 66,527 |
| Cash, beginning of year | 221,511 | 763,211 | 7,118,980 | 2,623,952 | 373,689 | 194,316 | 127,789 |
| Cash, end of year | 504,189 | 221,511 | 763,211 | 7,118,980 | 2,623,952 | 373,689 | 194,316 |
| Supplemental cash flow information: | |||||||
| Interest Expense | — | 129,981 | 14,191 | 239,011 | 63,152 | 97,147 | 153,824 |
| Business acquisition via stock issuance | — | — | — | 1,200,000 | — | — | — |
| Debt discount notes payable | — | — | — | — | 305,000 | — | — |
| Debt payments by sale of property and equipment | — | — | — | — | 1,232,500 | — | — |
| Gain on extinguishment of debt | — | — | — | — | 1,700,603 | — | — |
| Income Tax Expense | — | — | — | — | — | 18,533 | — |
| Net Cash from Financing Activities | — | — | — | — | — | 3,771,978 | 7,259,208 |
| Preferred stock conversion | 2 | — | — | — | — | — | — |
| Accrued dividends | 1,251,000 | 130,000 | — | — | — | — | — |
| Settlement of notes receivable in connection with asset purchase agreement | 1,044,000 | — | — | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.